Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Retractable TechnologiesRVP +1.06%40 Earnings Yield (Joel Greenblatt) % is 42.19% as of Mar. 2026, which is 158% above its 10-year median of 16.35. GuruFocus rates RVP with a GF Score™ of 40/100 and a GF Value™ of $0.75 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 848 Medical Devices & Instruments companies, Retractable Technologies ranks worse than 117924.41% on this metric.
Retractable Technologies's Enterprise Value for the quarter that ended in Mar. 2026 was $-14.67 Mil.
Retractable Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-6.20 Mil. Retractable Technologies's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was 42.19%.
The historical rank and industry rank for Retractable Technologies's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
RVP'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -270.52 Med: 16.35 Max: 239.26
Current: 43.67
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Retractable Technologies was 239.26%. The lowest was -270.52%. And the median was 16.35%.
RVP's Earnings Yield (Joel Greenblatt) % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.82
vs RVP: 43.67
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Retractable Technologies's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Retractable Technologies Earnings Yield (Joel Greenblatt) % Related Terms
Retractable Technologies Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Retractable Technologies's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Retractable Technologies's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Retractable Technologies Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Retractable Technologies's Earnings Yield (Joel Greenblatt) % falls into.
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Retractable Technologiess Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Retractable Technologies's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.20 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 42.19% mean?
Retractable Technologies (RVP) has a Earnings Yield (Joel Greenblatt) % of 42.19% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Retractable Technologies and its competitors. This is 158% above median its historical median of 16.35. According to the industry distribution chart, Retractable Technologies ranks #999999 out of 848 companies in the Medical Devices & Instruments industry.
Is Retractable Technologies' Earnings Yield (Joel Greenblatt) % too high?
Retractable Technologies' current Earnings Yield (Joel Greenblatt) % of 42.19% is 158% above median its 10-year median of 16.35. The Medical Devices & Instruments industry median Earnings Yield (Joel Greenblatt) % is 0.82. Retractable Technologies' value of 42.19% is 5045.1% above this industry median. Based on the distribution chart, Retractable Technologies ranks #999999 out of 848 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Retractable Technologies has a GF Score™ of 40/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Retractable Technologies' Earnings Yield (Joel Greenblatt) % compare to ZJYL and RGNT?
According to the Medical Devices & Instruments industry distribution chart, Retractable Technologies ranks #999999 out of 848 companies for Earnings Yield (Joel Greenblatt) %. This places Retractable Technologies in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.82. Retractable Technologies' value of 42.19% is 5045.1% above this benchmark. While the company's 10-year median is 16.35 vs. the industry median of 0.82, Retractable Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.82, based on 848 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Retractable Technologies's current Earnings Yield (Joel Greenblatt) % of 42.19% is 5045.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Retractable Technologies and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Retractable Technologies's current Earnings Yield (Joel Greenblatt) % is 42.19%, which is 158% above median its own 10-year median of 16.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Retractable Technologies stock overvalued right now?
Based on GuruFocus' analysis, Retractable Technologies (RVP) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.75, compared to a current price of $0.68 — trading 9.7% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 42.19%, which is 158% above median its 10-year median of 16.35 and 5045.1% above the Medical Devices & Instruments industry median of 0.82. Retractable Technologies' overall GF Score™ is 40/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Retractable Technologies (RVP), the current Earnings Yield (Joel Greenblatt) % is 42.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Retractable Technologies (RVP) Overvalued in 2026?
Based on GuruFocus' analysis, Retractable Technologies stock appears to be undervalued.
The current stock price of $0.68 is trading 9.7% below its estimated GF Value™ of $0.75.
GuruFocus considers Retractable Technologies to be Modestly Undervalued.
Key valuation signals for RVP:
Earnings Yield (Joel Greenblatt) %: 42.19% (158% above median its 10-year median of 16.35)
GF Value™: $0.75 vs. price of $0.68 (9.7% below fair value)
Industry Position: 5045.1% above the Medical Devices & Instruments median (#999999 of 848)
No single metric tells the full story. See the RVP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.
40GF Score
Get the complete analysis for RVP
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVP has been successfully added to your 
